Jun 4, 2020Alpha Tau Medical Announces Successful Completion of New $26 Million Funding RoundTel Aviv, Israel, June 4, 2020 - Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased...
Jun 3, 2020Lela’s Story of her Cancer Treatment Journey that Brought her to Alpha DaRTIntroduction When 78-year-old Israeli cancer patient Lela Parnes stumbled upon the Alpha DaRT treatment in 2017, with information from a...
Apr 7, 2020Alpha Tau Medical Announces Exclusive Distribution Arrangement with Medison Canada For Breakthrough Tel Aviv, Israel -- Alpha Tau Medical – the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, and Medison Canada – a...
Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Oct 14, 2018The Birth of Alpha Tau Medical – the Medicine Researcher PerspectiveCancer is the most devastating chronic disease affecting humankind. More than 1 out of 3 people in the United States will have cancer...